Spine Surgery Video Observation Study. The Creation of a Benchmark Video (RGB-Depth) Dataset to Investigate the Feasibility of Developing a Markerless Tracking System for Spine Surgery.
Launched by IMPERIAL COLLEGE LONDON · Aug 28, 2024
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Spine Surgery Video Observation Study aims to create a collection of videos that show different types of spine surgeries, both traditional and minimally invasive. The goal is to use these videos, along with pre-surgery CT scans (which are detailed images of the spine), to develop a new tracking system that can help surgeons perform spine surgeries more effectively without needing special markers on the patient's body. This study is important because it could improve how surgeries are done and ultimately lead to better outcomes for patients with spine issues like injuries or degeneration.
To participate in the study, patients must be between the ages of 65 and 74 and have a scheduled spine surgery that involves a posterior approach, meaning the surgery is done from the back of the body. If you're under 18 or if your doctor believes you may not be able to give informed consent, you won't be eligible to join. This study is not currently recruiting participants, but it offers a unique opportunity to contribute to advancements in spine surgery technology that could benefit many patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Candidate surgeries include all spine surgeries taking a posterior approach. This includes both 'open' and 'minimally invasive' surgeries, provided some portion of vertebrae bone is exposed.
- Exclusion Criteria:
- • Candidate surgeries will be excluded if the patient is under the age of 18 or the clinical lead feels the patient lacks capacity to consent.
About Imperial College London
Imperial College London is a world-renowned research institution based in the United Kingdom, recognized for its commitment to advancing medical science and improving patient care through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, Imperial combines expertise across various fields, including medicine, engineering, and business, to drive breakthroughs in healthcare. The institution’s robust clinical trial programs are designed to evaluate new therapies and interventions, ensuring rigorous scientific standards and ethical practices while aiming to translate research findings into tangible benefits for patients and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Salvatore Russo, MD
Principal Investigator
Imperial College Healthcare Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported